Larry CaiCBO at Defand TherapeuticsPresenter
Profile
Defand Therapeutics is a startup biotech with a patented target-oriented, cell-survival based, phenotypical high throughput screening platform, DEFUSE, which trail-blazes in searching of molecular glue degrader hits that can be developed into new therapeutics in oncology, immunology, neurodegeneration, metabolism, infection areas.
Agenda Sessions
Startup Spotlight Pitch Competition Sponsored by Pfizer
, 09:05View Session